Back to News
Market Impact: 0.3

IDXX Quantitative Stock Analysis

IDXXNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
IDXX Quantitative Stock Analysis

Validea's guru fundamental report indicates that IDEXX Laboratories (IDXX) is a strong fit for their P/B Growth Investor model, which is based on the strategy of Partha Mohanram and focuses on low book-to-market stocks with sustained growth characteristics. IDXX received a 77% rating based on its fundamentals and valuation, passing key criteria such as book/market ratio, return on assets, and cash flow metrics, while failing in advertising and capital expenditure to assets.

Analysis

IDEXX Laboratories Inc. (IDXX), a large-cap growth stock operating in the Fish/Livestock industry, has been evaluated by Validea's P/B Growth Investor model, based on Partha Mohanram's strategy, receiving a 77% rating. This model specifically targets low book-to-market stocks demonstrating characteristics associated with sustained future growth. While a score of 80% or higher typically indicates strategy interest, IDXX's 77% suggests a noteworthy alignment but not a strong conviction from this particular model. The company successfully passed several fundamental criteria, including Book/Market Ratio, Return on Assets, Cash Flow from Operations to Assets, the consistency between Cash Flow from Operations and Return on Assets, Return on Assets Variance, Sales Variance, and Research and Development to Assets. However, IDXX failed to meet the model's thresholds for Advertising to Assets and Capital Expenditures to Assets. The overall sentiment surrounding this specific report is moderately positive, with a more pronounced positive sentiment score of 0.7 attributed directly to IDXX.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.40

Ticker Sentiment

IDXX0.70
NDAQ0.00

Key Decisions for Investors

  • Investors should acknowledge IDEXX Laboratories' positive fundamental attributes highlighted by the Partha Mohanram model, particularly its strong performance in profitability, cash flow, and R&D investment, while noting the 77% score is slightly below the typical interest threshold for this specific growth strategy.
  • It is advisable to conduct further due diligence into why IDXX failed the criteria for Advertising to Assets and Capital Expenditures to Assets, assessing whether these reflect deliberate strategic choices or potential constraints on future growth.
  • Given the mixed signals from the model's criteria despite a generally positive sentiment for the stock, investors might consider this as one input among others, and closely monitor how the company's spending on advertising and capital projects evolves relative to its growth trajectory and peer benchmarks.